Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torque.
A cardinal feature of Parkinson's disease (PD) is muscle hypertonicity, i.e. rigidity. Little is known about the axial tone in PD or the relation of hypertonia to functional impairment. We quantified axial rigidity to assess its relation to motor symptoms as measured by UPDRS and determine whether rigidity is affected by levodopa treatment. Axial rigidity was measured in 12 PD and 14 age-matched controls by directly measuring torsional resistance of the longitudinal axis to twisting (+/-10 degrees ). Feet were rotated relative to fixed hips (Hip Tone) or feet and hips were rotated relative to fixed shoulders (Trunk Tone). To assess tonic activity only, low constant velocity rotation (1 degrees /s) and low acceleration (<12 degrees /s(2)) were used to avoid eliciting phasic sensorimotor responses. Subjects stood during testing without changing body orientation relative to gravity. Body parts fixed against rotation could translate laterally within the boundaries of normal postural sway, but could not rotate. PD OFF-medication had higher axial rigidity (p<0.05) in hips (5.07 N m) and trunk (5.30 N m) than controls (3.51 N m and 4.46 N m, respectively), which did not change with levodopa (p>0.10). Hip-to-trunk torque ratio was greater in PD than controls (p<0.05) and unchanged by levodopa (p=0.28). UPDRS scores were significantly correlated with hip rigidity for PD OFF-medication (r values=0.73, p<0.05). Torsional resistance to clockwise versus counter-clockwise axial rotation was more asymmetrical in PD than controls (p<0.05), however, there was no correspondence between direction of axial asymmetry and side of disease onset. In conclusion, these findings concerning hypertonicity may underlie functional impairments of posture and locomotion in PD. The absence of a levodopa effect on axial tone suggests that axial and appendicular tones are controlled by separate neural circuits.
Wright
W G
WG
Neurological Sciences Institute, Department of Neurology, Oregon Health & Science University, 505 NW 185th Ave, Beaverton, OR 97006, USA. wrightw@ohsu.edu
Gurfinkel
V S
VS
Nutt
J
J
Horak
F B
FB
Cordo
P J
PJ
D000005:Abdomen; D000054:Acceleration; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D005260:Female; D006615:Hip; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009122:Muscle Hypertonia / Q000209:etiology* / Q000503:physiopathology*; D009127:Muscle Rigidity / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy*; D011187:Posture; D012399:Rotation; D012720:Severity of Illness Index; D013909:Thorax; D019415:Torque
D000978:Antiparkinson Agents; D007980:Levodopa
Mov Disord. 2006 Aug;21(8):1088-97
16671073
J Neurol Neurosurg Psychiatry. 2000 May;68(5):595-600
10766889
Chin Med J (Engl). 1999 Sep;112(9):812-5
11717952
Eur Neurol. 1989;29 Suppl 1:13-8
2653833
J Spinal Disord. 1995 Aug;8(4):253-63
8547765
J Neurol Sci. 2006 Oct 25;248(1-2):196-204
16806270
Rinsho Shinkeigaku. 1996 Oct;36(10):1129-35
8997136
J Neurophysiol. 1996 Jun;75(6):2380-96
8793751
J Neurol. 2006 Nov;253(11):1404-13
16788773
Electroencephalogr Clin Neurophysiol. 1993 Aug;89(4):261-8
7688690
J Neurol Neurosurg Psychiatry. 1998 Feb;64(2):190-6
9489529
Neurology. 1988 Apr;38(4):540-5
3352908
J Neurol. 2007 Feb;254(2):202-9
17334954
Acta Neurol Scand. 1992 Sep;86(3):226-9
1414237
Prog Brain Res. 2004;143:231-7
14653168
J Neurophysiol. 2006 Nov;96(5):2678-87
16837660
Ergonomics. 2004 Mar 15;47(4):370-415
14680997
J Physiol. 1915 May 12;49(4):147-56
16993283
J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1245-54
15314109
J Neurol Sci. 1996 Feb;135(2):168-72
8867074
J Biomech. 1997 Jul;30(7):679-88
9239547
Mov Disord. 1997 Jan;12(1):24-32
8990050
Prog Brain Res. 1964;11:178-202
14300477
Rinsho Shinkeigaku. 1993 Jan;33(1):27-35
8334771
J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):72-6
2709038
J Gerontol A Biol Sci Med Sci. 2000 Aug;55(8):M441-5
10952366
Exp Brain Res. 2004 Jun;156(4):524-8
15127173
J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):815-21
16574736
Mov Disord. 2003 May;18(5):496-502
12722162
Neurology. 1982 Mar;32(3):246-51
7199634
Brain. 1992 Aug;115 ( Pt 4):1167-80
1393509
Can J Neurol Sci. 1995 Nov;22(4):280-5
8599770
Brain. 2003 Dec;126(Pt 12):2648-55
12937076
J Neurol Sci. 1985 May-Jun;69(1-2):37-46
4009205
J Neurosurg. 2005 Aug;103(2):252-5
16175854
J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):267-74
12185157
Brain Res. 1994 Nov 21;664(1-2):178-88
7895027
Clin Neurophysiol. 2007 Jul;118(7):1602-6
17452124
Clin Neurophysiol. 2006 Oct;117(10):2302-7
16920016
J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):645-8
8971118
J Spinal Disord. 1992 Dec;5(4):390-6; discussion 397
1490035